Pediatric Crohns Disease
18
0
0
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
3 terminated out of 18 trials
75.0%
-11.5% vs benchmark
17%
3 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Peer Mentoring to Improve Self-management in Youth With IBD
Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease
Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
Autophagy in Paediatric Crohn's Disease
PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Efficacy of a Low Fiber Diet for Pediatric Colonoscopy Prep
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Exercise Training in Youth With Inflammatory Bowel Disease
Clinical Hypnosis in Pediatric Crohn's Disease
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
FMT in Pediatric Crohn's Disease
Trial of Enhanced Pre-Consent Discussion
Mission is Remission®: How Can a Disease Self-management Website Change Care?
Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"
TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease
Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease